Clinical Trial Update: A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial to evaluate the safety, tolerability, and preliminary efficacy of Linvoseltamab in adults with recently diagnosed, treatment-naive multiple my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Linvoseltamab

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: RECRUITING